COMPLIANCE WITH NEW DRUGS IN GLAUCOMA THERAPY IN BENIN CITY, NIGERIA
Objective: To determine the compliance rate, reasons for default and factors affecting compliance with new drugs in glaucoma therapy.
Met,hod: Fifty-six new patients on medical therapy with the recent drugs for primary open-angle glaucoma were followed-up for a minimum duration of 3 months and a maximum of 9 months. The number of drug doses missed per week as well as the reasons for default were recorded. Compliant and non-compliant patients were also compared in terms of prescribed treatment and personal characteristics